Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Pharmacist Mitsui Becomes Health Minister, Industry Hails Appointment
October 2, 2012
-
BUSINESS Daiichi Sankyo, AZ to Step Up Promotion for Nexium upon Lifting of Long-Term Prescription Ban
October 1, 2012
-
REGULATORY Price Gap between Long-Listed Products, Generics Should Be Retained: Mr Chikazawa of MHLW
September 28, 2012
-
BUSINESS Takeda Aims to Become No. 1 in Domestic Diabetes, Cardiovascular Markets: Senior Vice Pres. Iwasaki
September 27, 2012
-
BUSINESS Japan Vaccine Pres. Nagano Eyes One-Third Market Share or More in FY2020
September 26, 2012
-
BUSINESS Sanofi-Aventis Looks to Clinical Evidence to Differentiate Lantus from Rival
September 25, 2012
-
ORGANIZATION MHLW Reports Results of Analysis of “Close-Call” Incidents at Pharmacies with Generics
September 24, 2012
-
BUSINESS Pfizer Preparing for Assault on Domestic Generic Drug Market with Help from Mylan
September 24, 2012
-
REGULATORY MHLW to Introduce Brand Name Rules for Combination Injectables to Prevent Medical Accidents
September 21, 2012
-
ORGANIZATION Dr Fukuda Lays Out 4 Options for HTA Introduction in Drug Pricing
September 20, 2012
-
ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences
September 19, 2012
-
BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin
September 18, 2012
-
BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug
September 14, 2012
-
REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
-
BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September
September 12, 2012
-
BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs
September 11, 2012
-
BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?
September 10, 2012
-
BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage
September 7, 2012
-
BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field
September 6, 2012
-
BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis
September 5, 2012
ページ
Pharmaceutical companies are giving high marks to Japan’s drug pricing reform for FY2024. According to a survey conducted by Jiho, 51% of all respondents expressed a positive opinion of the reform, saying that they were “somewhat satisfied” with it. The…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…